CytoSorbents Corporation (CTSO)

[Lakersrback]

I totally trust management. For me personally, the much bigger issue is the product itself. I have been scouring the net looking for data to make the efficacy of the product a clear and concise fact. Some of my concern is the fact there is not a companion diagnostic to confirm exactly what is happening with cytokine levels. The other issue is what are we doing to other more desired components of a patient's blood. Sometimes I wonder if the constant and questionable discussion around management is purposeful because it is easy to change management but changing the product is so much a different and unrealistic task. I still have a little bit left and personally feel like Chan and company have done a super job with the cards they've been dealt. I've yet to see compelling RCT data from anywhere and the FDA experience with REFRESH and now REFRESH II is not instilling any new confidence. Let's call a diamond a diamond here, the world is turning more and more to precision medicine, if we can't precisely detail what it is we are or are not doing to a patient's blood, it will continue to be an uphill battle. Just my opinion and good luck to all holders.